Figure 7.
RAP enhanced Dex-Ace-reduced TM cell autophagy and Dex-Ace-induced GIG-related protein expression at the 4th week. The relative protein expression levels of Beclin-1 and LC3-II/LC3-I ratio were upregulated, and p62 was downregulated in the Dex-Ace-treated group. RAP treatment further increased beclin-1 and LC3-II/LC3-I ratio, and downregulated p62 (A, B, C, D). Myocilin and a-actin were upregulated in the Dex-Ace-treated group and neutralized by RAP treatment (A, E, F). (n = 6; *, p < 0.05).